Current molecular changes in colorectal tumors are usually linked to the traditional determination of somatic mutations in well-known tumor-suppressor genes or oncogenes, such as p53, KRAS, and BRAF [21]. This evidence concerns the gene BRAF and colorectal neoplasm.